- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Mature B-cell Non-Hodgkin Lymphoma in United States
Total 3492 results
-
CRISPR Therapeutics AGActive, not recruitingB-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALLUnited States, Spain, Canada, France, Germany, Australia
-
National Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia (CLL) | Hairy Cell Leukemia (HCL) | Cutaneous T Cell Lymphoma (CTCL) | Non-Hodgkins Lymphoma (NHL) | Adult T Cell Lymphoma (ATL)United States
-
University of Southern CaliforniaCompletedRituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell LymphomaDiffuse, Large B-Cell, LymphomaUnited States
-
Brown UniversityWithdrawnDiffuse Large B Cell LymphomaUnited States
-
La Jolla Pharmaceutical CompanyWithdrawnDiffuse Large B-cell LymphomaUnited States
-
The Alvin and Lois Lapidus Cancer InstituteOrtho Biotech Products, L.P.UnknownLymphoma, Non-Hodgkin | Diffuse Large B Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteAbbVieRecruitingB-Cell Lymphoma | B-cell Acute Lymphoblastic Leukemia | ALLUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnProgressive Disease | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Minimal Residual Disease | Recurrent Chronic Lymphocytic Leukemia | CD19 Positive | CD22...United States
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.RecruitingDiffuse Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsTerminatedDiffuse Large B-cell LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyActive, not recruitingDiffuse Large B Cell Lymphoma | Transformed LymphomaUnited States
-
Ohio State University Comprehensive Cancer CenterMerck Sharp & Dohme LLCActive, not recruitingSezary Syndrome | Chronic Lymphocytic Leukemia | Peripheral T-Cell Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | T-Cell Prolymphocytic Leukemia | B-Cell Prolymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin LymphomaUnited States
-
Medical University of South CarolinaCelgene CorporationCompletedLarge B-Cell Diffuse LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
M.D. Anderson Cancer CenterGenentech, Inc.; CelgeneCompleted
-
ADC Therapeutics S.A.WithdrawnDiffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedLeukemia | Multiple Myeloma | MDS | Non-Hodgkins Lymphoma | Hodgkins LymphomaUnited States
-
Novartis PharmaceuticalsCompletedLymphoma, Non-HodgkinUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Waldenstrom... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedB Cell LymphomaUnited States
-
Weill Medical College of Cornell UniversityEpizyme, Inc.; Genentech, Inc.RecruitingLymphoma, Non-Hodgkin | Follicular Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
University of Wisconsin, MadisonMedical College of WisconsinRecruitingCancer | Diffuse Large B Cell Lymphoma | DLBCLUnited States
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaUnited States
-
Duke UniversityCompletedDiffuse Large B-cell LymphomaUnited States
-
Rush University Medical CenterElsa U. Pardee FoundationTerminatedDiffuse Large B-Cell LymphomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Molly GalloglyActive, not recruitingDiffuse Large B-cell-lymphomaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
Eli Lilly and CompanyCompletedT-Cell Lymphoma | B-Cell LymphomaMexico, United States, Australia, Brazil, Peru
-
ImmunityBio, Inc.WithdrawnLymphoma | Lymphoma, B-Cell | Diffuse Large B Cell Lymphoma | Large-cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedDiffuse Large B-Cell Lymphoma UnclassifiableUnited States
-
Baylor College of MedicineThe Methodist Hospital Research InstituteTerminatedNon-Hodgkin Lymphoma | Hodgkins LymphomaUnited States
-
Kite, A Gilead CompanyCompletedRelapsed Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | High Grade B-cell Lymphoma (HGBCL)United States, Netherlands, Canada, France, Germany, Israel
-
Weill Medical College of Cornell UniversityEpizyme, Inc.; American Society of Clinical Oncology; Applebaum FoundationRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-Cell LymphomaUnited States
-
Century Therapeutics, Inc.RecruitingAggressive Non-Hodgkin Lymphoma | R/R CD19-Positive B-Cell Malignancies | Indolent Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditionsUnited States
-
University of RochesterRecruiting
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular... and other conditionsUnited States
-
Carevive Systems, Inc.CompletedFollicular Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingHIV Infection | AIDS-Related Diffuse Large B-cell Lymphoma | AIDS-Related Primary Effusion Lymphoma | AIDS-Related Burkitt Lymphoma | AIDS-Related Plasmablastic Lymphoma | AIDS Related Non-Hodgkin LymphomaUnited States
-
Deepa JagadeeshCase Comprehensive Cancer CenterActive, not recruitingDiffuse Large B-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated
-
University of ChicagoNational Cancer Institute (NCI)TerminatedDiffuse Large B-Cell LymphomaUnited States
-
Hackensack Meridian HealthCelgene CorporationCompletedDiffuse Large B Cell LymphomaUnited States
-
City of Hope Medical CenterActive, not recruitingHIV Infection | AIDS-related Non-Hodgkin Lymphoma | AIDS-related Plasmablastic Lymphoma | AIDS-related Primary Effusion LymphomaUnited States
-
Medivation, Inc.WithdrawnLymphoma, Large B-Cell, Diffuse | Primary Mediastinal Large B-cell Lymphoma | Transformed Indolent LymphomaUnited States